Targeting PD‐L1 with DNA Aptamers and Conjugated with Gemcitabine as a Novel Therapeutic Strategy for Bladder Cancer Chemotherapy Combined with Immunotherapy.

Autor: Hu, Xing1 (AUTHOR), Zeng, Hongliang2 (AUTHOR), Peng, Yongbo3 (AUTHOR), Deng, Minhua4,5 (AUTHOR), Xiang, Wei1 (AUTHOR), Liu, Biao1 (AUTHOR), Liu, Jiahao1 (AUTHOR), Fu, Yunlong1 (AUTHOR), Hu, Zhiqiang1 (AUTHOR), Hou, Weibin1 (AUTHOR), Liu, Xuewen6 (AUTHOR), Tang, Jin1 (AUTHOR), Long, Zhi1 (AUTHOR), Wang, Long1 (AUTHOR), Liu, Jianye1 (AUTHOR) 602536@csu.edu.cn
Zdroj: Small Science. Dec2023, Vol. 3 Issue 12, p1-13. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje